Dianthus Therapeutics, Inc. (DNTH)
91.38
+3.90
(+4.46%)
USD |
NASDAQ |
Apr 09, 16:00
91.66
+0.28
(+0.31%)
After-Hours: 17:01
Dianthus Therapeutics Total Assets (Quarterly) : 531.40M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 1.260B |
| Sarepta Therapeutics, Inc. | 3.350B |
| Daré Bioscience, Inc. | 32.47M |
| Relmada Therapeutics, Inc. | 94.00M |
| Viridian Therapeutics, Inc. | 899.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.00M |
| Shareholders Equity (Quarterly) | 493.40M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 13.32 |
| Net Debt Paydown Yield | -0.01% |